medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2014, Number 2

<< Back Next >>

Rev Esp Med Quir 2014; 19 (2)

Botulinum toxin type-a as a treatment in chronic painful myofascial in patients who do not respond to conservative treatment

Aguirre SB, Gómez PBA

Language: Spanish
References: 12
Page: 152-155
PDF size: 402.13 Kb.


ABSTRACT

Performed assessment of patients with diagnosis of Myofascial Pain Syndrome, served in the Oral and Maxillofacial Service, with Visual Analogue Scale (VAS) and the Index of Functionality with the Modified Oswestry Question for 4 weeks, to obtain a sample of 20 female patients, they were served in the outpatient clinic with diagnosis of Chronic Miofascial Pain Syndrome of more than 3 months of duration. Clinically with presence of muscle strips and / or trigger points, with a partial response to conservative treatment. In a period from 1 March 2012 to 28 February 2013.


REFERENCES

  1. Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Anesthesiol Clin N Am. 2007;25:841-51

  2. Kurtoglu C, Gur OH, Kurkcu M, Sertdemir Y, Guler-Uysal F, Uysal H. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. Journal of Oral and Maxillofacial Surgery 2008;66:1644–51.

  3. Gül K, Onal SA. Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome. Agri 2009;21:104–12.

  4. Venancio Rde A, Alencar Jr FG, Zamperini C. Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches. Cranio 2009;27:46–53.

  5. Kuan TS. Current studies on myofascial pain syndrome. Current Pain and Headache Reports 2009;13:365–9.

  6. Sikdar S, Shah JP, Gilliams E, Gebreab T, Gerber LH. Assessment of myofascial trigger points (MTrPs): a new application of ultrasound imaging and vibration sonoelastography. Conf Proc IEEE Eng Med Biol Soc 2008;2008:5585–8.

  7. O.W. Majid: Clinical use of botulinum toxins in oral and maxillofacial surgery. Int J Oral Maxillofac Surg 2010;39:197–207.

  8. Sidebottom AJ, et al. Botulinum injection for the management of myofascial pain in the masticatorymuscles. A prospective outcome study. Br J Oral Maxillofac Surg (2012).

  9. Kurtoglu C, Gur OH, Kurkcu M, et al: Effect of botulinum toxin-A in myofascial pain patients with or without functionaldisc displacement. J Oral Maxillofac Surg 66:1644, 2008.

  10. Leonidas Manolopoulos, Petros V. Vlastarakos, Lucas Georgiou, Ioannis Giotakis, Anthony Loizos, Thomas P. Nikolopoulos: Myofascial pain syndromes in the maxillofacial area: a common but underdiagnosed cause of head and neck pain. Int J Oral Maxillofac Surg 2008;37:975–984.

  11. J.C. Torres Huerta, Toxina botulínica tipo A para el manejo del dolor en pacientes con síndrome de dolor miofascial crónico. Rev Soc Esp Dolor 2010;17(1):22-27.

  12. C. Kurtoglu, O.H. Gur. Effect of Botulinum Toxin-A in Myofascial Pain Patients With or Without Functional Disc Displacement. J Oral Maxillofac Surg 2008;66:1644-1651.




2020     |     www.medigraphic.com